David Reynolds

David Reynolds is the founder of LoQus23 Therapeutics. LoQus23 Therapeutics has raised $43M, latest Series A $43M (2024). Biotech · Cambridge, UK.

About David Reynolds

David Reynolds is the founder of LoQus23 Therapeutics. LoQus23 Therapeutics operates in Biotech and is based in Cambridge, UK. LoQus23 Therapeutics has raised $43M, latest Series A $43M (2024). Backers on record include Argeris Karabelas, Novartis Venture Fund.

David Reynolds at a glance

Company
LoQus23 Therapeutics
Industry
Biotech
Location
Cambridge, UK
Total raised
$43M
Investors on record
Argeris Karabelas, Novartis Venture Fund

Frequently asked about David Reynolds

Who is David Reynolds?
David Reynolds is the founder of LoQus23 Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did David Reynolds found?
David Reynolds founded LoQus23 Therapeutics, a Biotech company based in Cambridge, UK.
How do I contact David Reynolds?
Verified contact routes including LinkedIn, background and funding history for David Reynolds are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Cambridge — who backed them, at what stage, and how much they raised.

LoQus23 Therapeutics funding profile (1)

More Biotech founders (40)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library